Growing Calls for AI Regulation Amid Rising Concerns

Concerns are rising regarding the capabilities of AI models, prompting calls for government intervention to regulate the sector. Writer Robert Sirin suggests that the pharmaceutical industry could provide a model for managing these risks, as regulations evolved after past incidents. These calls come as Sam Altman, CEO of OpenAI, discusses the possibility of slowing down the development of advanced models. Jacob Coxon, a former researcher at Anthropic, resigned due to fears about the risks associated with developing self-improving models.